Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

RESTOR: PK/PD mTORi Inhibition in Older Adults — Stella

Home/Aging/RESTOR: PK/PD mTORi Inhibition in Older Adults

View on ClinicalTrials.gov

Recruiting

Back to Aging trials

RESTOR: PK/PD mTORi Inhibition in Older Adults

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

United States

The University of Texas Health Science Center at San Antonio, San Antonio, Texas

Key details

Phase

Very early testing

Sponsor

The University of Texas Health Science Center at San Antonio

Collaborators

National Institute on Aging (NIA)

Enrollment target

~194 participants

Started

August 2025

Primary completion

July 2028

Age range

65 Years – 90 Years

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.